20,821 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Occudo Quantitative Strategies LP

Occudo Quantitative Strategies LP acquired a new position in Doximity, Inc. (NASDAQ:DOCS) during the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 20,821 shares of the company’s stock, valued at approximately $1,112,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DOCS. Barclays PLC grew its stake in shares of Doximity by 60.5% during the third quarter. Barclays PLC now owns 53,401 shares of the company’s stock valued at $2,327,000 after buying an additional 20,125 shares during the last quarter. Franklin Resources Inc. boosted its holdings in Doximity by 564.1% during the 3rd quarter. Franklin Resources Inc. now owns 83,098 shares of the company’s stock valued at $3,487,000 after acquiring an additional 70,585 shares during the period. Wedmont Private Capital bought a new position in Doximity in the 4th quarter valued at $298,000. FNY Investment Advisers LLC purchased a new stake in Doximity in the fourth quarter worth $613,000. Finally, David J Yvars Group bought a new stake in shares of Doximity during the fourth quarter worth $1,119,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOCS has been the subject of a number of recent analyst reports. Needham & Company LLC boosted their target price on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Raymond James reaffirmed an “outperform” rating and set a $83.00 target price (up from $65.00) on shares of Doximity in a research report on Friday, February 7th. Morgan Stanley lowered their price target on Doximity from $71.00 to $60.00 and set an “equal weight” rating for the company in a report on Thursday, April 24th. Finally, The Goldman Sachs Group increased their price objective on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, Doximity currently has an average rating of “Moderate Buy” and a consensus target price of $65.39.

Doximity Trading Down 1.1%

DOCS opened at $60.38 on Wednesday. The firm has a market cap of $11.27 billion, a price-to-earnings ratio of 60.38, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12 month low of $23.27 and a 12 month high of $85.21. The stock has a fifty day moving average price of $57.71 and a 200-day moving average price of $57.52.

Insider Activity at Doximity

In other news, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the transaction, the chief financial officer now owns 357,165 shares of the company’s stock, valued at $20,440,552.95. The trade was a 11.19% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now directly owns 16,618 shares of the company’s stock, valued at $946,062.74. The trade was a 10.74% decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is owned by corporate insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.